<DOC>
	<DOCNO>NCT00205491</DOCNO>
	<brief_summary>The purpose study determine treatment venlafaxine reduces symptoms depression person traumatic brain injury .</brief_summary>
	<brief_title>Pharmacological Intervention Depression After Traumatic Brain Injury</brief_title>
	<detailed_description>The study evaluate benefit promise antidepressant medication treatment person traumatic brain injury ( TBI ) major depressive disorder ( MDD ) . The study randomize , double-blind , placebo-controlled trial venlafaxine ( serotonin norepinephrine reuptake inhibitor , also know Effexor ) . Venlafaxine well establish treatment MDD healthy individual recommend depression treatment agent person TBI . By use rigorous scientific methodology , study important first step advance treatment depression population beyond general impression prove treatment .</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Brain Injuries</mesh_term>
	<mesh_term>Venlafaxine Hydrochloride</mesh_term>
	<criteria>Must document traumatic brain injury ( TBI ) , define damage brain tissue cause external mechanical force evidence : loss consciousness due brain trauma , post traumatic amnesia ( PTA ) , skull fracture , objective neurological finding reasonably attribute TBI physical examination mental status examination . Age 18 year old At least three month postinjury Presence major depressive disorder ( MDD ) , define Structured Clinical Interview DSMIV ( SCID ) interview Hamilton Depression Rating Scale ( HamD ) score 18 great two consecutive evaluation ( screen baseline ) Individuals 18 year age Pregnancy , determine urine pregnancy screen Prisoners Individuals institutionalized Individuals cognitively capable complete SCID interview HamD Unstable medical condition , define significant medical condition likely require hospitalization study period , require adjustment medication past month Active suicidality Severe depression , investigator 's professional opinion , likely require hospitalization study time period Diagnosis bipolar disorder , define SCID interview Diagnosis schizophrenia psychotic disorder , define SCID interview , major depression psychotic feature Active drug alcohol abuse within past 3 month , define SCID interview Dysphagia sufficient preclude use oral medication Known hypersensitivity venlafaxine Use monamine oxidase inhibitor ( MAOI ) within past month Treatment antidepressant medication within past 3 month Concomitant administration medication interact venlafaxine clinically significant degree</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>depression brain injury</keyword>
	<keyword>traumatic brain injury</keyword>
	<keyword>Venlafaxine</keyword>
</DOC>